SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thierry Poynard, Françoise Imbert-Bismut, Zakim and Boyer's Hepatology, 2012,

    CrossRef

  2. 2
    Salvatore Petta, Claudio Tripodo, Stefania Grimaudo, Daniela Cabibi, Calogero Cammà, Antonietta Di Cristina, Vito Di Marco, Gaetano Di Vita, Sabrina Ingrao, Alessandra Mazzola, Giulio Marchesini, Rosaria Pipitone, Antonio Craxì, High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis, Digestive and Liver Disease, 2011, 43, 5, 404

    CrossRef

  3. 3
    Roberto Gambino, Giovanni Musso, Maurizio Cassader, Redox Balance in the Pathogenesis of Nonalcoholic Fatty Liver Disease: Mechanisms and Therapeutic Opportunities, Antioxidants & Redox Signaling, 2011, 15, 5, 1325

    CrossRef

  4. 4
    Maneerat Chayanupatkul, Sittisak Honsawek, Voranush Chongsrisawat, Linda Vimolket, Yong Poovorawan, Serum retinol binding protein 4 and clinical outcome in postoperative biliary atresia, Hepatology International, 2011, 5, 4, 906

    CrossRef

  5. 5
    S. Petta, V. Di Marco, R. Di Stefano, D. Cabibi, C. Cammà, G. Marchesini, A. Craxì, TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1, Journal of Viral Hepatitis, 2011, 18, 7
  6. 6
    Shen-Nien Wang, Yao-Tsung Yeh, Sen-Teh Wang, Yi-Ling Chen, Shih-Chang Chuang, Chen-Guo Ker, King-Teh Lee, Decreased Retinol Binding Protein 4 Concentrations are Associated With Cholesterol Gallstone Disease, Journal of the Formosan Medical Association, 2010, 109, 6, 422

    CrossRef

  7. 7
    G. Musso, R. Gambino, M. Cassader, Non-alcoholic fatty liver disease from pathogenesis to management: an update, Obesity Reviews, 2010, 11, 6
  8. 8
    Jeffrey R. Lewis, Smruti R. Mohanty, Nonalcoholic Fatty Liver Disease: A Review and Update, Digestive Diseases and Sciences, 2010, 55, 3, 560

    CrossRef

  9. 9
    Dan-Dan Wang, Yi-Ming Zhao, Lu Wang, Guang Ren, Fei Wang, Zu-Guang Xia, Xi-Long Wang, Tao Zhang, Qi Pan, Zhi Dai, Ju-Ping Chen, Hai-Yan Dai, Wei Zhang, Hong-Wei He, Jia-Min Zhou, Guang-Yu Tang, Jian Zhou, Jia Fan, Zhao-You Tang, Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection, Journal of Cancer Research and Clinical Oncology, 2010, 137, 4, 651

    CrossRef

  10. 10
    Cem Cengiz, Yasemin Ardicoglu, Safak Bulut, Sedat Boyacioglu, Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?, European Journal of Gastroenterology & Hepatology, 2010, 22, 7, 813

    CrossRef

  11. 11
    Timothy J. S. Cross, Mohammed M. Rashid, Philip A. Berry, Phillip M. Harrison, The importance of steatosis in chronic hepatitis C infection and its management: A review, Hepatology Research, 2010, 40, 3
  12. 12
    L. Valenti, S. Moscatiello, E. Vanni, A. L. Fracanzani, E. Bugianesi, S. Fargion, G. Marchesini, Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study, QJM, 2010, 104, 2, 141

    CrossRef

  13. 13
    Kerry-Lee Milner, David van der Poorten, Aimin Xu, Elisabetta Bugianesi, James G. Kench, Karen S. L. Lam, Donald J. Chisholm, Jacob George, Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease, Hepatology, 2009, 49, 6
  14. 14
    Fabio Marra, Cristiana Bertolani, Adipokines in liver diseases, Hepatology, 2009, 50, 3
  15. 15
    Maria Schina, John Koskinas, Dina Tiniakos, Emilia Hadziyannis, Savvas Savvas, Basil Karamanos, Emanuel Manesis, Athanasios Archimandritis, Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease, Hepatology Research, 2009, 39, 10
  16. 16
    Calogero Cammà, Salvatore Petta, Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future, Journal of Hepatology, 2009, 50, 4, 648

    CrossRef

  17. 17
    S. PETTA, C. CAMMÀ, V. DI MARCO, V. CALVARUSO, M. ENEA, F. BRONTE, G. BUTERA, D. CABIBI, A. CRAXÌ, Insulin resistance is a major determinant of liver stiffness in nondiabetic patients with HCV genotype 1 chronic hepatitis, Alimentary Pharmacology & Therapeutics, 2009, 30, 6
  18. 18
    Calogero Cammà, Salvatore Petta, Vito Di Marco, Fabrizio Bronte, Stefania Ciminnisi, Giusalba Licata, Sergio Peralta, Fabio Simone, Giulio Marchesini, Antonio Craxì, Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis, Hepatology, 2009, 49, 1
  19. 19
    S. Petta, C. Muratore, A. Craxì, Non-alcoholic fatty liver disease pathogenesis: The present and the future, Digestive and Liver Disease, 2009, 41, 9, 615

    CrossRef

  20. 20
    M. Iwasa, N. Hara, H. Miyachi, H. Tanaka, M. Takeo, N. Fujita, Y. Kobayashi, Y. Kojima, M. Kaito, Y. Takei, Patients achieving clearance of HCV with interferon therapy recover from decreased retinol-binding protein 4 levels, Journal of Viral Hepatitis, 2009, 16, 10
  21. 21
    Valerio Nobili, Naim Alkhouri, Anna Alisi, Simonetta Ottino, Rocio Lopez, Melania Manco, Ariel E. Feldstein, Retinol-Binding Protein 4: A Promising Circulating Marker of Liver Damage in Pediatric Nonalcoholic Fatty Liver Disease, Clinical Gastroenterology and Hepatology, 2009, 7, 5, 575

    CrossRef

  22. 22
    Jee-Fu Huang, Chia-Yen Dai, Ming-Lung Yu, Shyi-Jang Shin, Ming-Yen Hsieh, Chung-Feng Huang, Li-Po Lee, Kun-Der Lin, Zu-Yau Lin, Shinn-Chern Chen, Ming-Yuh Hsieh, Liang-Yen Wang, Wen-Yu Chang, Wan-Long Chuang, Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C, Journal of Hepatology, 2009, 50, 3, 471

    CrossRef

  23. 23
    Naim Alkhouri, Rocio Lopez, Michael Berk, Ariel E. Feldstein, Serum Retinol-binding Protein 4 Levels in Patients With Nonalcoholic Fatty Liver Disease, Journal of Clinical Gastroenterology, 2009, 43, 10, 985

    CrossRef

  24. 24
    Kerry-Lee Milner, Donald Chisholm, Jacob George, The many faces of hepatitis C: Liver disease and type 2 diabetes, Hepatology, 2009, 50, 3
  25. 25
    Jung Hyun Kwon, Seong Tae Park, Gi Dae Kim, Chan Ran You, Jin Dong Kim, Hyun Young Woo, Jeong Won Jang, Chang Wook Kim, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease, The Korean Journal of Hepatology, 2009, 15, 1, 59

    CrossRef

  26. 26
    Matthias Blüher, Anke Tönjes, Michael Stumvoll, Does retinol-binding protein 4 cause or reflect fatty liver disease?, Hepatology, 2008, 48, 1
  27. 27
    Frank Tacke, Ralf Weiskirchen, Christian Trautwein, Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis, Hepatology, 2008, 48, 5
  28. 28
    P. Ferenci, Peginterferon and ribavirin in HCV: Improvement of sustained viral response, Best Practice & Research Clinical Gastroenterology, 2008, 22, 6, 1109

    CrossRef

  29. 29
    Salvatore Petta, Calogero Cammà, Antonio Craxfi, Reply:, Hepatology, 2008, 48, 5
  30. 30
    Tetsuji Fujita, Retinol-binding protein 4 as a circulating marker of hepatic steatosis, Hepatology, 2008, 48, 5